ETH News

02.06.2017 | News

How killer cells take out tumours

The use of immunotherapy to treat cancer is celebrating its first successes – but there are still many knowledge gaps in the underlying mechanisms of action. In a study of mice with soft tissue tumours, ETH researchers have now shown how endogenous killer cells track down the tumours with the help of dormant viruses. Read more 

24.05.2017 | News

Revealing how neurons communicate

The ETH spinoff MaxWell Biosystems AG develops microelectrode platforms for electrophysiological tests on nerve cells, opening up new possibilities for pharmaceutical research. Now, the company received CHF 130,000 in starting capital from the Venture Kick initiative Read more 

10.01.2017 | News

In a simple way to great complexity

ETH microbiologists have succeeded in showing that nature produces one of the most complex known bioactive natural products in a staggeringly simple way. The molecule originates from bacteria living in sea sponges. In future, it may be possible to produce the agent very easily using biotechnology, making it an interesting avenue for cancer research. Read more 

03.11.2016 | News

Award for innovative cell culture technology

Researchers at ETH Zurich have developed a new cell culture method, which may very well enable to forgo certain tests on animals in the future. The scientists were awarded an international prize for more humane treatment of laboratory animals. Read more 

18.07.2016 | News

Visualising muscle disease

Researchers at ETH Zurich have developed a new marker substance for positron emission tomography (PET) that will allow them to monitor the progression of the degenerative muscle disease amyotrophic lateral sclerosis (ALS) in a patient’s brain. Read more 

19.04.2016 | News

Biosensors in the pharmaceutical industry

A Nobel prizewinning idea bears entrepreneurial fruit: an ETH Pioneer Fellow is applying knowledge about G-protein-coupled receptors to market a novel process for testing drugs. Read more 

14.03.2016 | News

Broccoli ingredient has positive influence on drug efficacy

Colon cancer cells that are pretreated with an ingredient found in cruciferous vegetables are more likely to be killed by a cancer drug that is currently in development, found ETH scientists. This is one of only a few examples of a food ingredient that, in moderate amounts, has a positive influence on the efficacy of a cancer drug. Read more 

19.02.2016 | News

Breaking the vicious circle of heart failure

In patients with heart failure, the pumping power of the heart decreases in a fatal downward spiral. Pharmacologists at ETH Zurich and the University of Zurich have now succeeded in breaking this vicious circle in the mouse model. Their approach could one day also benefit humans. Read more 

04.02.2015 | News

Detox and software for power grids

The ETH-Zurich spin-offs Versantis and Adaptricity are heralding the beginning of a new era of detoxification methods and managing power systems. The two fledgling companies reached the third and final round of the competition Venture Kick. Both spin-offs received CHF 130,000 each in seed capital. Read more 

12.12.2014 | Press release

ETH and University of Zurich launch Wyss Translational Center Zurich

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems. Read more 

 
 
Page URL: https://www.ethz.ch/en/news-and-events/eth-news/news.html
28.06.2017
© 2017 Eidgenössische Technische Hochschule Zürich